Siemens Unveils MR Oncology Applications and Dedicated Breast ... International Business Times, NY - Nov 30, 2008 In 2007, nearly 219000 new cases of prostate cancer were diagnosed in theUnited States. With prostate cancer as the second leading cause of cancerdeath in ...
Health Buzz: World AIDS Day and Other Health News U.S. News & World Report, DC - Last year, US News explained how robotic surgery and other newer technologies are tackling early-stage prostate cancer. This September, Nancy Shute ...
Failure to Diagnose Prostate Cancer Justice News Flash, FL - Nov 28, 2008 The PSA test is an extremely valuable screening tool because, while prostate cancer may not be detected on physical examination due to the inherent ...
Former NFL players praise heart-screening program Kansas City Star, MO - Nov 26, 2008 ... Hall of Fame ? include the NFL Player Joint Replacement Program; Assisted Living Benefits; ?Plan88? Dementia Benefits; and Prostate Cancer Screenings. ...
Former NFL players praise heart-screening program Trading Markets (press release), CA - Nov 27, 2008 "I do it for the kids, and it's about time I get to do it for myself," said Cherry, who took part in the prostate screening exam in October. ...
Don Perata?s Farewell Message as a Senator California Progress Report, CA - Nov 29, 2008 The same year, we increased access to breast cancer screening for low-income women, and created a prescription drug benefit for AIDS patients. ...
Health calendar The Salem News, MA - Nov 28, 2008 A Prostate Cancer Support Group meets the third Thursday of every month at 7:30 pm at Ledgewood Rehabilitation and Skilled Nursing Center at Beverly ...
Source: Google News
Recent News and Articles on the Keywords: prostate + benefits + screening Related to the article below (Last Update: 8/7/2008)
Prostate test advice for elderly won't stop debate The Associated Press - Aug 5, 2008 The panel did not recommend for or against prostate screening of men under 75 but suggested that doctors discuss the potential benefits and harms of the ...
Questions Prostate Screening Free Market News Network, FL - In the first update of its recommendations for prostate cancer screening in five years, the panel that sets government policy on preventive medicine said ...
MDs urged to quit prostate screens in elderly men The Associated Press - Aug 4, 2008 Most major US medical groups recommend doctors discuss the potential benefits and known harms of the prostate screening, or PSA test, with their patients ...
More drugs, less couch Minneapolis Star Tribune, MN - Aug 5, 2008 In the first update of its recommendations for prostate cancer screening in five years, the widely respected panel that sets government policy on preventive ...
Treating an enlarged prostate Abilene Reporter-News, TX - Aug 4, 2008 As a result, men who choose to have PSA tests to screen for prostate cancer should have a baseline PSA test before using these drugs, and another test six ...
Prostate Cancer Screening: What We Know and What We Need To Know - BS Kramer, ML Brown, PC Prorok, AL Potosky, JK … - Annals of Internal Medicine, 1993 - annals.highwire.org ... is the fact that the benefits of screening... unknown but substantial interval because screening introduces considerable ... survival of men with prostate cancer in ...
Screening for prostate cancer. A decision analytic view - MD Krahn, JE Mahoney, MH Eckman, J Trachtenberg, … - JAMA, 1994 - Am Med Assoc ... effects of screening for prostate cancer with prostate-specific antigen ... function
may identify individuals who will benefit from screening, but selecting ...
The importance of patient preference in the decision to screen for prostate cancer - AB Flood, JE Wennberg, RF Nease, FJ Fowler, J Ding … - Journal of General Internal Medicine, 1996 - Springer ... In summary, men generally lack information about the uncertain benefits and potential
risks of screening for and treating early-stage prostate cancer. ...
[CITATION]Screening Men for Prostate and Colorectal Cancer in the United States: Does Practice Reflect the … - BE Sirovich, LM Schwartz, S Woloshin - JAMA: The Journal of the American Medical Association, 2003 - JAMA ... to be screened for cancer are aware of the known mortality benefit of colorectal
cancer screening and the uncertain benefits of screening for prostate cancer. ...
Screening for prostate cancer - S Frankel, GD Smith, J Donovan, D Neal - The Lancet, 2003 - Elsevier ... live for another 10 years (the vast majority) should be offered prostatescreening. ...
should be fully informed of the risks and benefits of screening and then ...
Source: Google Scholar
Prostate Screening Benefits African-Americans
The American Cancer Society (ACS) recommendation to begin prostate cancer screening at a younger age in African-American men appears to be paying off. A study published in the Journal of Radiation Oncology Biology Physics (Vol. 57, No. 5: 1292-1296) suggests more African-American men have been diagnosed with earlier stage disease since 1997, when the recommendation was first made.
Prostate cancer is the most common cancer in American men, striking nearly 221,000 each year, and killing nearly 29,000. African-American men are more likely to develop the disease, and they tend to develop it younger and in more aggressive forms than men of other races.
For these reasons, ACS recommends that African-American men begin screening at age 45, or even younger if they have several relatives who have had prostate cancer. (For men at average risk, doctors are advised to offer screening and to discuss the benefits and limitations of testing and treatment beginning at age 50.)
Screening can detect prostate cancer at an early stage, when it is easier to treat. Men are given a blood test for prostate-specific antigen, or PSA, as well as a digital rectal exam (DRE). A normal PSA level is typically under 4 nanograms per milliliter (ng/mL) of blood. A man with a PSA between 4 and 10 has about a 25% chance of having prostate cancer, while a man with a PSA over 10 has about a 67% chance of having prostate cancer.
Racial Gap in PSA Shrinking
Previous studies have shown that African-American men tend to have higher PSA levels than white men when they are diagnosed with prostate cancer, meaning their disease is likely more advanced when it is found. Researchers from the University of Michigan wanted to compare PSA levels at diagnosis in white and African-American men, and see if those levels changed after the screening guideline was revised.
They studied more than 2,000 men who had been diagnosed with prostate cancer during two time periods: 1990-1996, before earlier screening was recommended; and 1997-2001, after the guideline was revised.
In both time periods, African-American men had higher PSA levels than white men at diagnosis, but the difference shrank over time. In the first period, black men had PSA levels 36% higher than whites; in the second period, their levels were just 13% higher.
That shift suggests more African-American men were being screened in the second period -- and thus, being diagnosed at an earlier stage of disease -- rather than getting the PSA test because they had disease advanced enough to cause symptoms, said lead researcher Charlie Pan, MD, a radiation oncologist at the University of Michigan.
The African-American men were also younger than the white men when they were diagnosed, and that gap widened over time, from 2.5 years in the first period to more than 3 years in the second period.
"The racial differences in initial PSA levels observed in the study suggest that African-American men are more susceptible at an earlier age to [prostate cancer] and should continue to be screened at a younger age than Caucasians, as recommended by the American Cancer Society in its screening guidelines," Pan said.
Durado Brooks, MD, director of prostate and colorectal cancer for ACS, said the new study reinforces the idea that PSA screening leads to earlier stage at diagnosis.
"It does appear that [screening] is benefiting African-American men at least to the same degree that it's benefiting Caucasian men," he said. "African-American men are being diagnosed at an earlier stage of disease, which hopefully means that their outcomes related to treatment will also improve."